Matthew G. Oser MD, PhD, is an Assistant Professor of Medicine at Harvard Medical School and a medical oncologist at Dana-Farber Cancer Institute in the Lowe Center for Thoracic Oncology. Dr. Oser completed his undergraduate studies at Oberlin College and received his MD and PhD degrees from the Albert Einstein College of Medicine, where his graduate training was in the lab of Dr. John Condeelis. He completed a residency in Internal Medicine at Brigham and Women’s Hospital followed by a fellowship in Medical Oncology in the Dana-Farber/Mass General Brigham program. His postdoctoral research was at the Dana-Farber Cancer Institute in the laboratory of Dr. William G. Kaelin Jr. His recognitions include a Lung Cancer Research Foundation Career Development Award, a NIH K08 career development award, a Damon Runyon Clinical Investigator Award, a Novartis Drug Discovery Translational Research Award, an AACR-Margaret Foti Foundation Early-Stage Investigator Award, and an R37 MERIT award. Dr. Oser has been invited to give national seminars at institutions including MD Anderson Cancer Center and Memorial Sloan Kettering Cancer Center, and talks at international meetings including the IASLC Hot Topic SCLC meeting and the IASLC World Conference on Lung Cancer. Dr. Oser has published his independent research in several high impact journals including Cancer Cell, Nature Cell Biology, and Cancer Discovery. Dr. Oser started his laboratory at the Dana-Farber Cancer Institute in 2019 and is focused on using CRISPR/Cas9 to understand mechanisms that control neuroendocrine differentiation in small cell lung cancer (SCLC) and to identify novel targeted therapies for SCLC.